Fundamental Analysis
37 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +5.7% | -1.0% | 1 / 3 | +22.3% | -4.78 pp | -38.65 pp | +7.0% | 0.00 | 11.24 | 9,1 | +22,3% | 22,5 | +5,7% | 11.24 | 15.21 | −26,1% |
| Pts | 0 | 0 | 4 | 12 | 0 | 0 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 13.900 (close price on 2026-10-19)EPS (TTM): 1.236
Financial charts
1.Revenue & growth
VND bn9,15Q2/26
1.Revenue & growth
VND bn9,15Q2/26
2.Profit & growth
VND bn22,5Q2/26
3.Profit mix (Penman)
VND bn105Q2/26
4.Margins & cost structure
%43.3%Q2/26
5.Returns & cash cycle
% · days-2.1%Q2/26
6.Earnings quality & cash
VND bn-45,8Q2/26
7.Asset structure
VND bn1.245Q2/26
8.Funding & debt health
VND bn · times1.245Q2/26
9.Revenue backlog
VND bn2,07Q2/26
10.Valuation
times · %11,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %332Q2/26
Adjusted EPS growth, latest quarter
5.7%
Average adjusted EPS growth, 3 quarters
-1.0%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26